These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhaled insulin (exubera). Med Lett Drugs Ther; 2006 Jul; 48(1239):57-8. PubMed ID: 16841019 [No Abstract] [Full Text] [Related]
3. Insuline glusine (Apidra): a new rapid-acting insulin. Med Lett Drugs Ther; 2006 Apr; 48(1233):33-4. PubMed ID: 16625142 [TBL] [Abstract][Full Text] [Related]
4. [Insulin treatment of type 1 diabetes in adults]. Birkeland KI Tidsskr Nor Laegeforen; 2006 Mar; 126(6):776-8. PubMed ID: 16541173 [No Abstract] [Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes. Porcellati F; Rossetti P; Ricci NB; Pampanelli S; Torlone E; Campos SH; Andreoli AM; Bolli GB; Fanelli CG Diabetes Care; 2007 May; 30(5):1261-3. PubMed ID: 17303785 [No Abstract] [Full Text] [Related]
7. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus. Mathieu C Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394 [TBL] [Abstract][Full Text] [Related]
8. Improving post-prandial control with Humalog and Humalog mixtures. Lüddeke HJ Int J Clin Pract Suppl; 2000 Sep; (112):23-8. PubMed ID: 11064948 [No Abstract] [Full Text] [Related]
9. [Types and choice of the treatment in diabetes mellitus]. Goto Y; Abe R; Hori S Nihon Rinsho; 1990 Dec; 48 Suppl():803-9. PubMed ID: 2128349 [No Abstract] [Full Text] [Related]
10. 2008 resource guide. Insulin. Along with human insulin analogs, recombinant DNA human insulins are the most widely used insulins in this country. Through genetic engineering, bacteria or yeast are transformed into little "factories" that produce synthetic human insulin. Diabetes Forecast; 2008 Jan; 61(1):RG11-4. PubMed ID: 18290288 [No Abstract] [Full Text] [Related]
11. Insulin detemir (levemir), a new long-acting insulin. Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022 [TBL] [Abstract][Full Text] [Related]
12. Humalog--a new insulin analogue. Drug Ther Bull; 1997 Aug; 35(8):57-8. PubMed ID: 9350086 [No Abstract] [Full Text] [Related]
15. From the control tower: some is better than none and a little bit goes a long way. Geffner ME J Pediatr; 2001 Dec; 139(6):766-8. PubMed ID: 11743498 [No Abstract] [Full Text] [Related]
16. [Diabetic patient with insulin analog treatment. More flexible meal regimen]. MMW Fortschr Med; 2001 Feb; 143(7):60. PubMed ID: 11268756 [No Abstract] [Full Text] [Related]
17. [What is new in the treatment of diabetes mellitus?]. Gain T Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350 [No Abstract] [Full Text] [Related]
18. Rationale for using combinations of short-acting insulin analogue and NPH insulin at mealtime in the treatment of type 1 diabetes mellitus. Bolli GB J Pediatr Endocrinol Metab; 1999; 12 Suppl 3():737-44. PubMed ID: 10626264 [No Abstract] [Full Text] [Related]
19. Devices for insulin administration. Hill J Nurs Times; 2003 Apr 15-21; 99(15):51-2. PubMed ID: 12733296 [TBL] [Abstract][Full Text] [Related]
20. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting. Hahr AJ; Molitch ME Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]